Track Nath Bio-Genes (India) Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nath Bio-Genes (India) Limited NATHBIOGEN.NS · Stock Open Nath Bio-Genes (India) Limited in new tab

165.43 INR
P/E
8.34
EPS
20.97
Yield
1.18%
Safety Score
52
P/B
0.57
ROE
6.29
Beta
0.94
Loading chart...
Key Metrics
Earnings dateJune 24, 2026
P/E8.34
EPS20.97
Book Value304.36
Price to Book0.57
Debt/Equity20.35
% Insiders61.696%
Growth
Revenue Growth-0.01%
Earnings Growth-0.37%
Dividend
Dividend Yield1.18%
Annual dividends2.00 INR
Ex-Div. DateAug. 14, 2025
Payout8.70%

DCF Valuation

Tweak assumptions to recompute fair value for Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nath Bio-Genes (India) Limited Logo Nath Bio-Genes (India) Limited Analysis (NATHBIOGEN.NS)

India Materials Official Website Stock

Is Nath Bio-Genes (India) Limited a good investment? Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) is currently trading at 165.43 INR.

In terms of valuation, the stock trades at a P/E ratio of 8.34. This relatively low multiple may signal that Nath Bio-Genes (India) Limited is undervalued compared to historical market norms.

Earnings Schedule: Nath Bio-Genes (India) Limited is expected to release its next earnings report on June 24, 2026.

For income investors, Nath Bio-Genes (India) Limited pays a dividend yield of 1.18%. With a payout ratio of 9%, the dividend appears sustainable.

Investor FAQ

Does Nath Bio-Genes (India) Limited pay a dividend?

Yes, it pays an annual dividend of 2.00 INR (1.18% yield).

What asset class is Nath Bio-Genes (India) Limited?

Nath Bio-Genes (India) Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be June 24, 2026. The company currently has a trailing EPS of 20.97.

Company Profile

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win-Chi-Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company was founded in 1979 and is based in Mumbai, India.

Exchange Ticker
NSI (India) NATHBIOGEN.NS
Trades
Dividend Yield
1.18%
Annual Dividends
2.00INR
Next Ex. Div Date
Aug. 14, 2025
Payout Ratio
8.70%
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
2026
2.00 INR
Sept. 28, 2026 (estimated) 2.0000
2025
2.00 INR
Sept. 21, 2025 2.0000
2024
2.00 INR
Sept. 16, 2024 2.0000
2023
2.00 INR
Aug. 10, 2023 2.0000
2022
2.00 INR
June 23, 2022 2.0000
2021
2.00 INR
Sept. 26, 2021 2.0000
Upcoming Dividends
Name Payment Date Status Amount
Nath Bio-Genes (India) Limited Sep 21, 2025 2.0 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion